By Mill Chart
Last update: Apr 14, 2025
Exploring Growth Potential: EXELIXIS INC (NASDAQ:EXEL) and Its Base Formation. Growth investors seek promising revenue and EPS growth, and EXELIXIS INC has come under our scrutiny for potential growth investing. While it's crucial to do your own research, we've detected EXELIXIS INC on our screen for growth with base formation, suggesting it merits a closer look.
A key component of ChartMill's stock assessment is the Growth Rating, which spans from 0 to 10. This rating evaluates diverse growth factors, such as EPS and revenue growth, considering both past performance and future projections. EXEL has received a 8 out of 10:
Every stock is evaluated by ChartMill, receiving a Health Rating on a scale of 0 to 10. This assessment considers different health aspects, including liquidity and solvency, both in absolute terms and relative to industry peers. EXEL has achieved a 9 out of 10:
ChartMill's Profitability Rating offers a unique perspective on stock analysis, providing scores from 0 to 10. These ratings consider a wide range of profitability metrics and margins, both in comparison to industry peers and on their own merits. For EXEL, the assigned 8 is a significant indicator of profitability:
ChartMill provides a Setup Rating for each stock. This rating, ranging from 0 to 10, assesses the level of consolidation in the stock based on multiple short-term technical indicators. Currently, EXEL has a 8 as its setup rating, indicating its current consolidation status.
Although the technical rating is only medium, EXEL does present a nice setup opportunity. Prices have been consolidating lately. There is a resistance zone just above the current price starting at 35.57. Right above this resistance zone may be a good entry point.
More Strong Growth stocks can be found in our Strong Growth screener.
Check the latest full fundamental report of EXEL for a complete fundamental analysis.
Our latest full technical report of EXEL contains the most current technical analsysis.
This is not investing advice! The article highlights some of the observations at the time of writing, but you should always make your own analysis and invest based on your own insights.
42.86
-0.86 (-1.97%)
Find more stocks in the Stock Screener
EXELIXIS INC (NASDAQ:EXEL) offers strong growth, solid profitability, and an attractive valuation, making it a compelling choice for investors seeking affordable growth stocks in the biotech sector.
EXELIXIS INC (NASDAQ:EXEL) is an undervalued biotech stock with strong profitability, financial health, and growth potential, making it a candidate for value investors.
EXELIXIS INC (NASDAQ:EXEL) meets Minervini’s Trend Template with strong technicals and high growth momentum, making it a standout in biotech. Review its full technical and fundamental strengths before considering an investment.